The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer

Keyphrases

• Esophageal Cancer 100%
• Gastric Cancer 100%
• Gastroesophageal Cancer 100%
• Checkpoint Inhibitors 100%
• Evolving Roles 100%
• Immune Checkpoint Inhibitors 100%
• Tumor 50%
• Inflammation 50%
• Lung Cancer 50%
• Melanoma 50%
• Cancer Genome Atlas 50%
• Malignancy 50%
• Tumor Subtype 50%
• Clinical Trial Data 50%
• Molecular Heterogeneity 50%

Medicine and Dentistry

• Malignant Neoplasm 100%
• Immune Checkpoint Inhibitor 100%
• Esophageal Cancer 100%
• Stomach Cancer 100%
• Neoplasm 50%
• Cancer 50%
• Clinical Trial 50%
• Lung Cancer 50%
• The Cancer Genome Atlas 50%
• Tumor 50%
• Inflammation 50%
• Melanoma 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Immune Checkpoint Inhibitor 66%
• Neoplasm 33%
• Clinical Trial 33%
• Inflammation 33%
• Lung Cancer 33%
• Melanoma 33%